Literature DB >> 19717385

Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature.

Suzanne Cole1, Hagop Kantarjian, Patricia Ault, Jorge E Cortés.   

Abstract

The management of patients with chronic myeloid leukemia (CML) during pregnancy is a matter of continued debate. We present a 21-year-old woman in whom CML was diagnosed during early pregnancy. Because the patient was asymptomatic and desired to carry the pregnancy to term while minimizing fetal exposure to medication, she was observed with no therapy for the duration of her pregnancy. The white blood cell count showed a slow downward trend throughout her pregnancy. She delivered a healthy baby and breast fed for a time before initiating therapy for CML. We reviewed the published case reports of women who had a pregnancy occur in the setting of treatment with imatinib. Given the adverse effects of fetal exposure to imatinib as treatment for the mother with CML, close observation might be an option for selected patients who are diagnosed with CML while pregnant and who have minimal clinical manifestations of CML.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19717385     DOI: 10.3816/CLM.2009.n.064

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma        ISSN: 1557-9190


  14 in total

Review 1.  Fertility considerations in young women with hematological malignancies.

Authors:  Pascale Jadoul; S Samuel Kim
Journal:  J Assist Reprod Genet       Date:  2012-05-22       Impact factor: 3.412

Review 2.  How I treat newly diagnosed chronic phase CML.

Authors:  Jorge Cortes; Hagop Kantarjian
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

3.  Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy.

Authors:  Monika Conchon; Sabri S Sanabani; Mariana Serpa; Mafalda M Y Novaes; Luciana Nardinelli; Patrícia B Ferreira; Pedro Enrique Dorliac-Llacer; Israel Bendit
Journal:  Adv Hematol       Date:  2010-03-07

4.  Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy.

Authors:  A Mukhopadhyay; S Dasgupta; U Kanti Ray; F Gharami; C K Bose; S Mukhopadhyay
Journal:  Ir J Med Sci       Date:  2014-03-04       Impact factor: 1.568

Review 5.  Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester.

Authors:  Soley Bayraktar; Belline Morency; Maricer P Escalón
Journal:  BMJ Case Rep       Date:  2010-10-21

6.  Long-term imatinib diminishes ovarian reserve and impacts embryo quality.

Authors:  Wael Salem; Jacqueline R Ho; Irene Woo; Sue A Ingles; Karine Chung; Richard J Paulson; Lynda K McGinnis
Journal:  J Assist Reprod Genet       Date:  2020-05-06       Impact factor: 3.412

7.  A case of chronic myelogenous leukemia in pregnancy characterized by a complex translocation t(9;22;11)(q34;q11.2;q13).

Authors:  Surachit Kumar; Mariya Apostolova; Paul V Woolley
Journal:  Hematol Rep       Date:  2011-11-21

Review 8.  Fertility considerations in targeted biologic therapy with tyrosine kinase inhibitors: a review.

Authors:  Anupama Rambhatla; Michael R Strug; Jessica Garcia De Paredes; Marcos I Cordoba Munoz; Mili Thakur
Journal:  J Assist Reprod Genet       Date:  2021-04-07       Impact factor: 3.357

9.  A newborn with teratogenic effect of imatinib mesylate: a very rare case report.

Authors:  Namita Jain; Deepak Sharma; Renu Agrawal; Adeesh Jain
Journal:  Med Princ Pract       Date:  2015-04-17       Impact factor: 1.927

10.  Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study.

Authors:  Monika Conchon; Sabri S Sanabani; Israel Bendit; Fernanda Maria Santos; Mariana Serpa; Pedro Enrique Dorliac-Llacer
Journal:  J Hematol Oncol       Date:  2009-10-06       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.